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ABSTRACT
Members of the Staphylococcus genus are found as a part of normal microflora in humans and
can commonly be found on the skin or in the nasal cavity. However, these microorganisms can
cause serious and life-threatening opportunistic infections when there is a break in the physical
barrier of skin. These infections have become difficult to treat as resistant strains emerge,
particularly Methicillin Resistant Staphylococcus aureus (MRSA). MRSA has become a
commonly acquired nosocomial infection which is difficult to treat with conventional antibiotics
of the b lactam class. Even Vancomycin, a last resort antibiotic, has been ineffective on some
infections. Furthermore, S. aureus readily forms biofilms on implanted medical devices which
establishes a hardy and difficult to treat infection. These biofilms serve as a point of infection to
the bloodstream. Research involving polymicrobial interactions and the inhibitory effects of
bacterial-bacterial interactions could be a starting point for the discovery of a new therapeutic
treatment for infections. It has been shown in our lab that Alcaligenes faecalis has inhibitory
effects on Staphylococcus aureus planktonic growth. Therefore, in this study, we wanted to
examine 1) The mechanism by which A. faecalis inhibits S. aureus growth and 2) how A.
faecalis impacts the various phases of S. aureus biofilm growth. It was found that A. faecalis
likely inhibits S. aureus using a physical mechanism that requires close contact, rather than using
a secreted molecule. However, a Type VI secretion system could also produce similar results.
Further research involving the formation of mutants to find the gene allowing A. faecalis to
inhibit S. aureus was started, but no viable mutants were created during the course of this
research. A. faecalis was found to inhibit the formation of S. aureus biofilm growth, but when
added to a mature S. aureus biofilm, the slow growth rate of A. faecalis could not overtake the
quickly replicating S. aureus. Further research in the polymicrobial interactions between S.
aureus and A. faecalis could lead to a finding of a new therapeutic target for antibiotics or the
use of A. faecalis in infections.
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INTRODUCTION
Antibiotics and Antibiotic Resistance
Antibiotics are one of the greatest achievements in medicine of the 20th century. Since the
discovery of penicillin in 1928, antibiotics have been used to save countless lives from life
threatening infections worldwide [1],[2]. In the United States, antibiotic treatment helped to
replace the leading causes of death from infectious diseases to non-communicable diseases,
increasing the average life expectancy from 47 to 78 years [2]. Unfortunately, pathogens have
developed resistance to these drugs over time, and presently antibiotic resistance is a top concern
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to public health [3]. Resistance to antibiotics was first observed in 1940 in the same lab penicillin
was discovered, even before the antibiotic was developed for use in medicine [1]. According to
the Centers for Disease Control and Prevention (CDC), 2.8 million people are infected with
resistant strains of bacteria ultimately causing 35,000 deaths annually in the United States [4].
Antimicrobial resistance is due to a number of mechanisms including beneficial mutations that
bacteria accumulate over time as they replicate or acquire antibiotic resistant plasmids due to
selective pressures put upon them by the very antibiotics we use to treat infections. Those
bacteria that are resistant to antibiotics survive to reproduce generations of resistant bacteria [3].
Bacteria that are resistant to one type of antibiotic are dangerous, but increasingly,
bacteria are becoming multidrug resistant, leading to increased mortality. Once a bacterial
population has become resistant to one type of drug, alternate drugs that are typically reserved
for more serious infections must be used. Due to the misuse of antibiotics, this process occurs
even faster, causing what are termed “superbugs” [5]. Superbugs are multidrug resistant bacteria,
leaving few or no options for treatment. An example of a bacterial species that has gained
resistance is Methicillin Resistance Staphylococcus aureus (MRSA). This bacterium can be
spread through skin to skin contact [6]. Although it is typically known as a nosocomial infection,
or an infection acquired in a hospital, anyone can contract MRSA [6]. Strains of MRSA are
becoming better adapted for transmission to other people outside the hospital in a community
setting [7]. It is a difficult infection to treat, with vancomycin as the last remaining antibiotic to
treat these infections [7]. If left untreated, it can eventually result in life threating infections of
the bloodstream and sepsis [6].
The problem does not end with drug resistance. Most modern medical practices and
procedures rely on antibiotics to ensure that an infection does not get out of hand. Without them,
common medical procedures become much more dangerous. It suddenly becomes very risky to
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perform surgery, provide cancer treatments like chemotherapy, or even give birth due to the risk
of acquiring an infection that is unable to be treated with antimicrobial drugs [8]. Without these
drugs, all recent medical advances are much more difficult to perform. The world would lose
years of progress in medicine if bacteria gain resistance to all the antibiotics used to treat them
[8]. Alternative methods to treat bacterial infections are needed, and the aim of this research is to
provide a possible alternate way to combat infections using the natural inhibition mechanisms
microorganisms possess.
Competitive Polymicrobial Interactions
Natural environments contain a variety of diverse microbial species which are continually
competing with one another for limited resources using a variety of mechanisms [9]. For
example, bacteria produce numerous antimicrobial compounds to target competitors. These
antibiotic agents can be either broad spectrum or highly specific, depending on the environment
that the bacteria inhabit [9]. Streptomyces species inhabiting microbially diverse soil
environments produce a wide array of broad acting antimicrobial compounds [9]. On the other
hand, some bacterial species produce bacteriocins, a type of antimicrobial peptides, that kill other
closely related bacterial species [9],[10].
Another mechanism of competition is the uptake of nutrients to restrict access to these
nutrients from other species [9],[11]. An example of this can be seen through the acquisition of
iron required for growth [9]. Some bacterial species produce siderophores, which bind ferric iron
to capture it from the environment and then import the iron into the bacterial cell [9],[10]. For
example, the bacterium Pseudomonas aeruginosa uses siderophore production to acquire and
deplete iron from the environment as a mechanism of competition [12]. Pseudomonas
aeruginosa also acquires iron by lysing Staphylococcus aureus cells during coinfections of the
lungs in cystic fibrosis patients.
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Lastly, there are predatory bacteria that can ingest other bacteria in order to kill them
[13]. Some bacteria such as Myxococcus use a predatory approach to swarm upon target bacteria,
while others like Vampirococcus act more like vampires as they suck the life out of their prey
[14]. Another species, Bdellovibrio, bores into its prey and develops in the periplasm of Gramnegative species ultimately causing the target bacteria to lyse [14],[15]. No resistance
mechanisms have been found for this type of predation, making it a highly effective way to kill
target bacteria [14].
Quorum sensing is an important factor in polymicrobial competition to promote
collective behavior within a population [16]. For instance, to be effective, antibiotic agents have
to be produced in large amounts [9]. If these compounds are continuously released at subinhibitory levels, the target bacteria can become tolerant and the compounds lose effectiveness
[9]. One method that bacteria use to combat this is quorum sensing, in which the compounds are
not released until sufficient cell numbers are present as indicated through extracellular signals
[9]. This ensures that necessary inhibitory levels of the antimicrobial agent for the target bacteria
would be produced, minimizing the chance for tolerance towards the compound [9]. Quorum
sensing is also a factor in biofilm formation, which is an important biological process that can
make infections difficult to treat with antibiotics [16].
Biofilms
Biofilms occur when bacteria and other microbes grow as a community-like film on a
surface, encased in a slimy complex [17]. It is understood that microbes primarily exist in this
state, rather than in their planktonic, or free-floating, form [18]. Examples of biofilms that form
in-vivo are dental plaques, lung biofilm formed by P. aeruginosa in cystic fibrosis patients, and
biofilms on the surface of implanted devices [17]. Today the use of implanted devices such as
catheters or cardiac pacemakers has become a common part of modern medicine [17].
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Staphylococcus aureus and Staphylococcus epidermidis biofilms from the patient’s own normal
flora or acquired through a nosocomial infection are both commonly found infecting implanted
medical devices that patients depend on [17]. These biofilm infections become much more
difficult to treat than the typical planktonic form of the bacteria, as they are more resistant to
antibacterial agents [19].
In a laboratory setting, bacteria are in their less hardy form [19]. While in the
environment, they must be able to survive harsh or inhospitable environments and have
developed protective measures to do this [19]. Biofilm colonies are encapsulated in a
carbohydrate polysaccharide capsule to provide protection from the environment [17]. Bacteria
encased in the biofilm matrix are protected from phagocytes and other immune defenses, as well
as antibiotics [17]. This decreased susceptibility to antibiotics is partly due to the slower growth
and metabolic state the bacteria are in when in a biofilm state [16]. It has been shown that the
concentration of antibacterial compounds may need to be more than a thousand times the
concentration necessary to treat the planktonic forms in order to be effective against biofilms
[19].
Oftentimes, it is not a single species in a biofilm. There are many examples of
polymicrobial biofilms, the best example being the biofilms that form in the oral cavity [18].
Certain microbes in the oral cavity rely on another species to first form a biofilm and form a
“scaffolding” for them to then attach to the oral surfaces. This is called coaggregation, and
bacteria may do this in order to maximize space and access to nutrients [18]. Another example is
shown in cystic fibrosis, as coinfection with S. aureus and P. aeruginosa biofilms has negative
impacts on treatment options. The biofilm of P. aeruginosa releases an exoproduct that causes S.
aureus biofilm and planktonic cells to become less sensitive to vancomycin, the drug used to
treat resistant strains of the bacteria [20]. Cross-kingdom interactions also occur, as shown in the
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relationship between Candida albicans and S. aureus biofilm growth on implanted medical
devices. The complex relationship between these two organisms leads to hardier biofilms that are
more resistant than pure biofilms of the species and may also impact growth rate within the
biofilm [21]. Understanding these polymicrobial interactions within biofilms is important due to
the change in the clinical course of a disease and the change in antibiotic sensitivity in the
presence of a polymicrobial infection [22].
Staphylococcus Genus and Staphylococcus aureus
The genus Staphylococcus are Gram-positive, and therefore have a thick layer of
peptidoglycan in their cell wall, providing protection from desiccation in dry environments [7].
Cells aggregate in grape-like clusters [7]. There are around 30 known species of Staphylococcus,
with S. aureus as the only primary human pathogen [7]. Other Staphylococcal species such as S.
epidermidis cause opportunistic infections and infections of implanted medical devices such as a
catheter [7]. These bacterial species, particularly S. aureus, can commonly be found as a part of
the normal microbiota of humans [7]. Around 40% of the general population is colonized with S.
aureus, where it can be found on the skin, in the throat, nose, and vagina [7]. Therefore,
infections of S. aureus are oftentimes “autoinfections” where the source of the infection is from a
person’s own microbiota [7].
The virulence factors of this pathogen include attachment factors such as Protein F on the
surface of cells which allows this bacterium to bind to human fibronectin while other surface
adhesions allow this species to bind to human collagen and elastin [7]. Clumping factor is a
surface adhesin that binds to fibrinogen in blood plasma, helping the bacteria to attach to the
endothelial cells of blood vessels [7]. S. aureus also has multiple antiphagocytic factors such as a
polysaccharide capsule and produces “leukocidin”, a toxin that kills white blood cells [7]. An
example of this toxin in Staphylococcus is the alpha toxin [7]. Still another virulence factor is
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Protein A, a surface protein that binds to the Fc region of immunoglobulins to inhibit their
opsonization properties [7]. Coagulase activates blood coagulation by converting prothrombin to
thrombin. Fibrin may coat the surface of bacteria in order to cloak the bacterium in a human
protein to avoid recognition by phagocytes [7]. Other toxins released by Staphylococcus include
spreading factors such as staphylokinase, DNase, and hyaluronidase enzymes [7]. Enterotoxin
causes food poisoning, and exfoliate toxin causes the disease scaled skin syndrome [7]. Lastly,
the TSST-1 toxin, causes the deadly toxic shock syndrome [8]. These virulence factors give S.
aureus the ability to spread easily throughout the body and to evade natural host defenses.
Staphylococci species are receiving increased attention due to their significance in
causing morbidity and mortality in hospitalized patients. Currently, S. aureus is among the
leading pathogens in bloodstream and systemic infections [22]. S. aureus is an especially
dangerous pathogen due to its ability to resist many antibiotics. Penicillin and many of its
derivatives are no longer effective against S. aureus. Some strains of S. aureus have adapted to
have b lactamase activity which cleaves the b lactam ring on penicillin inactivating the
compound [23]. Even methicillin, a derivative of penicillin that is modified to be resistant to b
lactamase activity, is no longer effective against the strain of S. aureus called Methicillin
Resistant Staphylococcus aureus, or MRSA [23]. There are few antibiotics available today to
treat resistant S. aureus infections and the remaining few are used sparingly so to avoid future
resistant strains. Vancomycin is used as a last resort to combat the resistant strains of S. aureus,
but there are reports of resistant strains to this antibiotic as well [23].
Alcaligenes faecalis
A. faecalis is a Gram-negative, rod shaped, or bacilli, organism with peritrichous flagella
[24]. It is an aerobic organism, nonfermentive, oxidase-positive, urease-negative, and indolenegative organism [24],[25]. The name of the genus, Alcaligenes, is due to its ability to produce
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an alkaline reaction in certain media [26]. A. faecalis inhabits the environment in soil, water, and
is sometimes even found in human intestinal flora and hospital environments [26]. Alcaligenes
faecalis is usually non-pathogenic, but cases of endocarditis, meningitis, peritonitis, and
abscesses have been reported [26]. Most infections have been nosocomial, and most commonly
occur in those who are immunocompromised as a result of contamination of hospital equipment
[26]. If A. faecalis enters the bloodstream, it can be a difficult infection to treat due to the large
amount of antibiotic resistance genes in its chromosome [25].
The most significant virulence factor of A. faecalis are genes for antibiotic resistance,
however, there have been other virulence factors discovered such as histamine sensitizing factor,
adherence and cytotoxicity, and the extracellular ‘o’ antigen [25]. Most of the studies involving
virulence factors were conducted on avian and mammalian cells to test susceptibility. The same
virulence factors could potentially apply to human cells as well [25]. Alcaligenes has the
potential for widespread use in the environment due to the capability of pollutant bioremediation,
for example, with minimal impact on human health [25].
Objectives and Present Work
In the past, diseases were associated with one microorganism. However, as research
methods have developed, many diseases are now being classified as polymicrobial infections
[18]. Determining what microorganisms are present in the infection can determine how the
disease will progress and the predict severity of the disease [18]. Understanding the
polymicrobial interactions among these infectious agents is important as the different
combinations of microbes can impact how treatment will be responded to. For instance, some
bacterial infections that are coinfected with fungal species can affect antibiotic treatment [16].
Antifungals may also be less effective if there is a coinfection with a bacterial species [16].
Knowledge of these interactions is an important area of research as a better understanding can

11

lead to new therapeutic interventions and an understanding of why previous interventions may
not work [16].
Our lab has previously indicated that Alcaligenes faecalis has inhibitory effects on
Staphylococcus aureus planktonic growth. To further understand the extend of the inhibitory
effects of A. faecalis on S. aureus growth, our goal was to research the interactions between the
two bacteria in biofilm growth and with varying concentrations of the two organisms. We also
explored whether different stages of S. aureus biofilm growth were affected by A. faecalis
inhibitory action. Understanding the inhibitory mechanisms of A. faecalis may provide us insight
on new interactions between microorganisms, but also provide new targets for potential
therapeutics for S. aureus infections.
METHODS
Strains, Culture, and Experimental Growth: A. faecalis strains and handling. A. faecalis
strain ATCC 8750 was cultured from freezer stocks onto Luria Broth (LB) agar plates and
incubated at 37oC overnight to generate stocks used for the experiments. All subsequent LB
liquid cultures were obtained from the colonies formed on these plates. S. aureus strain and
handling. S. aureus strain ATCC 25923, and S. aureus clinical isolate strain were cultured from
freezer stocks onto Mannitol Salt Agar (MSA) plates and incubated at 37oC overnight to generate
strains used for the experiments. S. aureus strain ATCC 25923 is capable of biofilm formation in
vitro. All subsequent LB liquid cultures were obtained from the colonies formed on these plates.
For experiments involving the use of A. faecalis and S. aureus grown together, MSA plates were
used to isolate and select for the growth of S. aureus. E. coli strains and handling. E. coli strain
containing pRL27 was cultured from freezer stocks onto LB agar plates and incubated at 37oC
overnight to generate strains used for the experiments. This strain encodes the kanamycin
resistant Tn5 transposon plasmid. This was used for transposon mutagenesis to discover mutants
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that did not show inhibition of S. aureus. LB plates containing the antibiotics Kanamycin
(50µg/ml) and Ampicillin (100µg/ml) were used for the isolation of A. faecalis mutants.

Agar Spot Test: Overnight cultures, LB broth 37⁰C shaking (250rpm), of S. aureus were used to
spread bacterial lawns on two LB agar plates using a sterile cotton swab dipped into the liquid
culture. On the first plate four 20µl drops from an overnight culture of A. faecalis were placed on
the lawn of S. aureus. On the second plate, eight disks each containing A. faecalis (20 µL) were
placed on the lawn of S. aureus. Both plates were incubated at 37oC for 24 h and were observed
the next day to measure zones of inhibition (ZOI) at the Alcaligenes inoculation sites.

Cell Dependent Interaction Test: To determine if the presence of Alcaligenes cells were
necessary to cause inhibition or if there are secreted factors causing the inhibition of S. aureus,
an overnight A. faecalis culture was centrifuged to separate the cells from the liquid culture and
passed through a 0.22µm filter. A lawn of S. aureus was made on a LB plate and both 20µl of an
overnight A. faecalis culture and 20µl of the cell-free supernatant A. faecalis culture was spotted
onto the surface. This plate was incubated for 24 hours at 37⁰C and monitored for ZOI. Another
variation of this test was done as an agar spot test to test for concentration dependent increases of
ZOIs. An overnight culture of A. faecalis was added to four different microcentrifuge tubes,
centrifuged for 5 min at 10,000 rpm, the liquid was discarded, and the pellet was resuspended in
varying amounts of PBS (500 µL, 250 µL, 125 µL, and 60 µL). After a lawn of S. aureus was
created on a LB plate the varying concentrations of A. faecalis (20 µL) were spotted onto the
surface, the plate was incubated at 37oC for 24 h, and ZOI were measured to determine the
impact of the differing concentrations.
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Biofilm growth studies. Overnight cultures of S. aureus and A. faecalis were used to seed 6well cell culture plates. To add the appropriate number of cells to each well, the optical density
OD600 of both cultures were determined. S. aureus was inoculated to an OD600 reading of 0.01
(~1x106 cells/ml) and A. faecalis was inoculated to an OD600 reading of 0.1 (~1x108 cells/ml).
Attachment phase of biofilm growth. The well plates were inoculated to contain a S. aureus
monoculture control and a S. aureus/A. faecalis co-culture suspended in 2000µl of LB and
incubated for 24 or 48 hours at 37⁰C. After the 24 or 48 hours, a pipet was used to carefully draw
off the LB broth and loose cells from each well. PBS (1 mL) was gently added to wash off nonadherent cells and discarded. Another 1 mL of PBS was added gently to each well before using
the tip of the pipet to vigorously scrape off the biofilm formed on the bottom of each well and
suspend in the PBS liquid. These suspensions were serially diluted and plated on MSA,
incubated for 24 hours at 37⁰C, and CFUs were enumerated. Maturation phase of biofilm
growth. To see if A. faecalis can inhibit already established S. aureus biofilms, we followed the
above protocol for attachment except A. faecalis was not added to the 6-well plate until after the
S. aureus was allowed to grow 24 hours prior. A. faecalis was then added to the experimental
wells and incubated for 24 hours. Wells were then washed, scrapped, serially diluted and plated
on MSA. Concentration dependent inhibition. An overnight culture of A. faecalis was added
to four different microcentrifuge tubes, centrifuged for 5 min at 10,000 rpm, the liquid was
discarded, and the pellet was resuspended in varying amounts of PBS (500 µL, 250 µL, 125 µL,
and 60 µL). These different concentrations were then used to inoculate cocultures with S. aureus
in the 6-well plates as described in the biofilm attachment protocol. Plates were incubated for 24
h at 37oC, wells washed with PBS, serially diluted, and plated on MSA to enumerate CFUs.
Biofilm Formation on Coverslips. To view the amounts of A. faecalis and S. aureus after a
coculture of the two species, coverslips were placed in the bottom of a six-well plate before
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adding A. faecalis and S. aureus to the wells. After incubating for 24 h at 37oC the coverslips
were carefully taken out, washed, and placed on a microscope slide. The coverslips were fixed to
the slide, stained using the Gram stain method, and examined under the microscope using the
100X objective to view the differing amounts of A. faecalis and S. aureus.

Transposon Mutagenesis of Alcaligenes faecalis: Overnight cultures of A. faecalis (500µl) and
E. coli pRL27 (500µl) were combined, centrifuged for 5 min at 10,000 rpm, liquid was drawn
off, and replaced with 1mL of LB. The pellets were resuspended and four 20 µL drops were
placed on an LB plate and allowed to incubate for 24 h at 37oC. The next day the resulting cocolonies were resuspended in an LB tube and serially diluted. The dilutions were plated on LB
plates that contained Kanamycin and Ampicillin and the plates were incubated for 24 h at 37oC.
Kanamycin eliminated any A. faecalis that did not integrate the pRL27 transposon and
Ampicillin eliminated the E. coli that remained, so that the only colonies that would grow were
A. faecalis cells that had incorporated the transposon into their genome that contained the
Kanamycin resistance gene. These colonies were spot replicated onto another LB
Kanamycin/Ampicillin plate to confirm the dual resistance. These potential mutants were
screened against S. aureus for their potential loss of function phenotype.

RESULTS AND DISCUSSION
A. faecalis shows inhibition of S. aureus on solid media.
Lawns of S. aureus created on LB plates showed zones of inhibition around spot tests of
A. faecalis cells (Figure 1). These ZOIs at 24 hours are very robust, large, and clear zones. Upon
further incubation, the zones become cloudy with S. aureus minimal growth. We believe, that A.
faecalis has a much slower generation time than the quickly growing S. aureus. Thus, while
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initially inhibited at 24 hours, the S. aureus eventually overtakes the A. faecalis ability to inhibit.
Another experiment using disks saturated with A. faecalis placed on a lawn of S. aureus also
showed ZOI (Figure 1). However, this experiment shows slightly smaller zones of inhibition.
This experiment displays that A. faecalis likely inhibits S. aureus using a contact dependent
method. The A. faecalis cells are embedded in the disks and are not able to diffuse out of the
disks to make contact with S. aureus as easily. If a molecule was responsible for the inhibition, it
would be able to diffuse out of the disk and a larger zone of inhibition would occur around the
disks. Ultimately, these experiments exhibit the inhibiting nature of A. faecalis on S. aureus
growth on a solid medium.

Figure 1: Spot test inhibition of S. aureus by A. faecalis. (Left) An LB plate with a lawn of S.
aureus grown with 20µl drops of A. faecalis shows inhibition around the drops. (Right) An LB
plate with a lawn of S. aureus grown with 20µl of A. faecalis embedded on disks placed on top
of the lawn shows inhibition around the discs.
A. faecalis cells must be present to inhibit growth of S. aureus on solid media.
To examine the mechanism by which A. faecalis inhibits S. aureus, A. faecalis liquid
cultures were centrifuged and the liquid was drawn off and filtered. This was to determine
whether A. faecalis secreted a molecule as a form of inhibition toward S. aureus or whether it
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was a physical mechanism by the A. faecalis cell itself. The A. faecalis drops on a S. aureus lawn
did not show ZOI when the cells were filtered out while spots that contain the cells show the
characteristic ZOI (Figure 2). This indicates that there is a physical mechanism by which A.
faecalis inhibits S. aureus and a secreted molecule is likely not the cause of inhibition.

Figure 2: Cell free vs cell inhbition of A. faecalis. (Left) An LB plate with a lawn of S. aureus
(clinical strain) grown with 20µl drop of A. faecalis cells shows inhibition and 20µl of cell free
A. faecalis growth liquid shows no inhibition around the drops. (Right) An LB plate with a lawn
of S. aureus (laboratory strain) grown with 20µl drop of A. faecalis cells shows inhibition and
20µl of cell free A. faecalis growth liquid shows no inhibition around the drops.
A. faecalis exhibits increased inhibition against S. aureus with increasing cell-density.
The concentration of Alcaligenes inoculum was manipulated to examine whether an increasing
concentration of A. faecalis cells showed an increase in S. aureus inhibition. This was performed
by using a standard sample of A. faecalis along with four varying dilutions of A. faecalis, thus
each drop had a reduced amount of liquid volume creating 2X, 4X, 8X, and 16X concentrations
of A. faecalis. These were dropped onto a lawn of S. aureus in 20µl amounts and the resulting
ZOI were measured. As depicted in Figure 3 and 4, the concentration of A. faecalis increased the
ZOI on the S. aureus lawns.
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Figure 3: Concentration dependent inhibition of A. faecalis on S. aureus agar plates. ZOIs
slightly increased as the concentration increased of A. faecalis drops placed on a lawn of S.
aureus.

Figure 4: Inhibition by A. faecalis increases as the cell density increases. Graphical
representation of increasing inhibition of S. aureus growth as the concentration of A. faecalis was
increased.
A. faecalis concentration and inhibition of S. aureus biofilm (attachment phase) of growth.
Biofilms develop in discreet stages, with the attachment phase the initial step to biofilm
formation. To examine the inhibitory effects of A. faecalis on S. aureus biofilm attachment
growth, cocultures of A. faecalis and S. aureus were made, inoculated into 6 well plates, and
tested under varying time conditions. The first condition was a coculture grown for 24 hours.
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The wells were plated on MSA plates to select for S. aureus growth following the methods
outlined in the serial dilution procedure. The results indicate that there were inhibitory effects on
the biofilm attachment growth of S. aureus after a coculturing with A. faecalis and comparing the
colony forming units (CFU) to the control plates (Figures 5 and 6). Microscopic photos of
coverslips in the bottom of the 6-well plates show that the monoculture of S. aureus produces
thick robust biofilms (S. aureus Gram stains positive) while S. aureus coculture biofilms with A.
faecalis (A. faecalis Gram stains negative) show a dramatic reduction in S. aureus biofilm
attachment (Figure 7).

Figure 5: CFUs of mono and coculture biofilms 24h. (Top row) S. aureus monoculture
biofilm attachment growth without the addition of A. faecalis. (Bottom row) S. aureus coculture
biofilm attachment growth with the addition of A. faecalis. From left to right shows serial
dilutions and CFUs on MSA plates.
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Figure 6: Graphical representation of CFUs from S. aureus mono and coculture biofilm
attachment growth with A. faecalis 24h.
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Figure 7: Microscopic images of S. aureus mono and coculture biofilm attachment growth
with A. faecalis. (Top photo) Biofilm attachment growth of S. aureus monoculture on a
coverslip after 24 h of growth. (Bottom photo) Biofilm attachment growth of S. aureus
coculture on a coverslip after 24 h of growth with A. faecalis.
After finding the results above, we wanted to see if this inhibition of biofilm attachment
by A. faecalis on S. aureus would be sustained over a longer period of time or, if like the agar
plates experiments, S. aureus can overcome the inhibition. Another trial was performed using the
same methods as in Figures 5, 6, and 7, but the coculture was grown for an additional 24 hours
for a total of 48 hours. These plates also showed inhibition on biofilm growth, but the increased
time the coculture was grown did not have a significant impact, less than 10% reduction, on the
inhibitory effects of A. faecalis on S. aureus (Figure 8 & 9). This is likely due to the slower
growth rate of A. faecalis compared to S. aureus. Over time, S. aureus growth eventually
overtakes A. faecalis growth. It initially has a great inhibitory effect on S. aureus and it will keep
inhibiting S. aureus, but it does not overtake it due to the fast growth rate of S. aureus.
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Figure 8: CFUs of mono and coculture biofilms 48h. (Top row) S. aureus monoculture
biofilm attachment growth without the addition of A. faecalis. (Bottom row) S. aureus coculture
biofilm attachment growth with the addition of A. faecalis. From right to left shows serial
dilutions and CFUs on MSA plates.

Figure 9: Graphical representation of CFUs from S. aureus mono and coculture biofilm
attachment growth with A. faecalis 48h.
We wanted to examine a later stage of biofilm growth and the inhibitory effects of A.
faecalis on S. aureus on biofilm growth. This phase, the maturation phase of biofilms, considered
the effects of adding A. faecalis 24 hours after a S. aureus biofilm had been allowed to reach a
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mature phase. This experiment was performed in order to determine the inhibitory effectiveness
of A. faecalis on S. aureus after a mature biofilm was already established. A. faecalis showed
slight inhibitory effects on mature S. aureus biofilm growth and could have potentially destroyed
some of the existing biofilm there were less CFUs on the MSA plates from S. aureus grown with
A. faecalis (Figure 10). However, there was less inhibition exhibited from this experiment than
the previous attachment experiments.

Figure 10: CFUs of mono and coculture biofilms after allowing S. aureus to grow initially
for 24 hours. (Top row) S. aureus monoculture biofilm attachment growth without the addition
of A. faecalis. (Bottom row) S. aureus coculture biofilm attachment growth with the addition of
A. faecalis. From right to left shows serial dilutions and CFUs on MSA plates.

23

Addition of AF After 24h SA Biofilm Growth
9
8

CFU (log10)

7
6
5
4
3
2
1
0
Control

S. aureus CFUs

AF

Figure 11: Graphical representation of CFUs from S. aureus mono and coculture biofilm during
the mature phase of growth with the addition of A. faecalis after S. aureus was allowed to grow
for 24h.
A. faecalis concentration and inhibition of S. aureus biofilm growth.
We found in earlier experiments that the concentration of A. faecalis affects agar plate
interactions. We then wanted to examine if this finding could be translated to biofilm growth of
S. aureus. There was no noticeable difference when increasing concentrations of A. faecalis upon
the biofilms of S. aureus growth. There was still a significant reduction by A. faecalis on biofilm
growth of S. aureus, but the increasing amounts of A. faecalis did not cause a decrease in biofilm
growth beyond the 1X concentration (Figures 11 and 12).
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Figure 12: Concentration dependent inhibition of A. faecalis on S. aureus biofilm growth.
CFUs decreased at the same amounts despite the concentration increase of A. faecalis cocultured
in biofilms of S. aureus. (Top row in descending order) S. aureus monoculture, S. aureus with
1X concentration of A. faecalis, S. aureus with 2X concentration of A. faecalis, S. aureus with
3X concentration of A. faecalis.

Figure 13: Inhibition by A. faecalis various cell densities on S. aureus biofilms. Graphical
representation of inhibition of S. aureus biofilm growth (CFUs) as the concentration of A.
faecalis was increased.
Transposon mutagenesis to determine genetic elements of A. faecalis inhibition.
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Currently, the mechanism that A. faecalis utilizes to inhibit S. aureus is unknown. To
begin to identify the genetic elements involved in this interaction, we utilized random transposon
mutagenesis to screen A. faecalis for loss-of-function mutations. Using E. coli BW20767 that
possess the conjugative pRL27, a pir-dependent hyperactive Tn5 transposon system, and confers
Kanamycin resistance. Upon conjugation with A. faecalis, numerous potential mutants were
created and screened on lawns of S. aureus to look for A. faecalis colonies that lost the ability to
create ZOIs. Unfortunately, none of the mutants displayed the particular phenotype. However, a
research group using the same transposon system in a different bacterium screen 10,000 mutants
to only find seven mutants with the correct phenotype. We plan on continuing the conjugative
transposon method to saturate the A. faecalis genome.

Figure 14: Representative photo depicting one trails of transposon mutagenesis on double
antibiotic selection plates.
CONCLUSION
Bacteria and other microbes are becoming increasingly resistant to the antimicrobials currently
available for use. As the number of deaths from resistant infections rises, our increased
understanding of the countless polymicrobial interactions that are occurring in our environment
and inside our bodies is essential in improved treatments for resistant infections. Discovering the
variety of mechanisms microorganisms use to compete and interact with each other hold endless
potential for the creation of novel antibiotics or antimicrobial treatments. This preliminary
research evaluates a physical mechanism that A. faecalis employs to inhibit S. aureus growth. Of
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particular interest is the ability of A. faecalis to inhibit S. aureus biofilms at both the attachment
and the maturation phases of growth. On agar plate growth and in the initial attachment phases of
biofilm growth, A. faecalis is a potent inhibitor of S. aureus. Additionally, this inhibition is cell
density dependent with more concentrated amounts of A. faecalis having increased inhibition
qualities. However, in mature established S. aureus biofilms, the inhibition appears muted and
increased concentrations of A. faecalis have no change in the amount of inhibition. This appears
to be attributed to the slower generation time of A. faecalis in respect to the much faster doubling
times of S. aureus. The mechanism of this inhibition remains elusive at this time as preliminary
transposon mutagenesis of A. faecalis has not yielded a phenotypically significant mutant.
Further research involving the creation of a library of A. faecalis mutants to discover the genes
that allows the inhibition would be the next step in this project.
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